References
Riedel N, Laubner K, Lautenbach A, et al. Trends in BMI, glycemic control and obesity-associated comorbidities after explantation of the duodenal-jejunal bypass liner (DJBL). Obes Surg. 2018 Mar 4;28:2187–96. https://doi.org/10.1007/s11695-018-3144-9.
Muñoz R, Dominguez A, Muñoz F, et al. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients. Surg Endosc. 2014 Apr;28(4):1056–62.
Lässle C, Laubner K, Schwacha H, Seufert J, Grueneberger JM, Fischer A, Karcz WK, Hopt UT, Marjanovic G, Kuesters S. Endoscopy. 2014;46 Suppl 1 UCTN:E171-2. Minimally invasive treatment of a duodenal perforation associated with the EndoBarrier duodenal-jejunal bypass liner
Escalona A, Pimentel F, Sharp A, et al. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg. 2012 Jun;255(6):1080–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Human and Animal Rights
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Kassir, R., Gugenheim, J., Amor, I.B. et al. Trends in BMI, Glycaemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL). OBES SURG 28, 3629–3630 (2018). https://doi.org/10.1007/s11695-018-3438-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-018-3438-y